Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review

Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review

Abstract Introduction Tenofovir alafenamide (TAF) is approved for paediatric use in fixed‐dose combination tablets, but efficacy and safety data in children are limited. We conducted a systematic review on the efficacy/effectiveness and safety of TAF in infants, children and adolescents living with...

Full description

Bibliographic Details
Main Authors: John O'Rourke, Claire L. Townsend, Edith Milanzi, Intira Jeannie Collins, Hannah Castro, Ali Judd, Marissa Vicari, Julie Jesson, Valériane Leroy, Martina Penazzato, Françoise Renaud
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Journal of the International AIDS Society
Subjects:
children
drug‐related side effects and adverse reactions
HIV
systematic review
tenofovir
treatment outcome
Online Access:https://doi.org/10.1002/jia2.26037

Internet

https://doi.org/10.1002/jia2.26037

Similar Items